Clinical Trials Directory

Trials / Completed

CompletedNCT06899880

Perfusion Parameters and Outcome During a Standardized Deresuscitation Strategy with Net Ultrafiltration: a Retrospective Cohort Study.

Status
Completed
Phase
Study type
Observational
Enrollment
120 (actual)
Sponsor
Hospices Civils de Lyon · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

Hemodynamic tolerance of fluid removal during deresuscitation is a cornerstone of the impact on outcome of such a strategy. However, how to define and to predict hemodynamic tolerance to fluid removal remains controversial. The investigators routinely use a standardized deresuscitation protocol in patients with fluid overload and continuous renal replacement therapy combined with monitoring of clinical and biological perfusion parameters. The aim of the study was to describe perfusion during deresuscitation, and to determine whether it is associated with major adverse kidney events at day 30.

Conditions

Interventions

TypeNameDescription
OTHERDescribe the perfusion parameters during a deresuscitation strategy and their association with the outcome.Arterial lactate, pCO2 gap, SvO2, capillary refill time and mottling score anomalies will be described during the first 5 days of the deresuscitation strategy.

Timeline

Start date
2024-01-01
Primary completion
2024-03-01
Completion
2024-04-01
First posted
2025-03-28
Last updated
2025-03-28

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06899880. Inclusion in this directory is not an endorsement.

Perfusion Parameters and Outcome During a Standardized Deresuscitation Strategy with Net Ultrafiltration: a Retrospectiv (NCT06899880) · Clinical Trials Directory